Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
about
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer.TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.Computational identification of multi-omic correlates of anticancer therapeutic response.Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.Breast tumor metastasis: analysis via proteomic profiling.Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems.Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis.Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domainmiR-150 inhibits terminal erythroid proliferation and differentiation.Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.TDAG51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts.Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice.FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation.RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcomaUp-regulation of TDAG51 is a dependent factor of LPS-induced RAW264.7 macrophages proliferation and cell cycle progression.TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma.Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma.Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours.Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas.Transcriptionally inducible Pleckstrin homology-like domain family A member 1 attenuates ErbB receptor activity by inhibiting receptor oligomerization.PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1PHLDA1, another PHLDA family protein that inhibits Akt
P2860
Q28655621-3FEA1556-055E-4D5D-AD11-16B223BC1874Q30385880-544C6FFB-80B3-4E00-A354-841C72971A4BQ33348778-D5729DF9-FC4C-478D-BDA9-D37FDD425CD3Q34374852-0AA9435D-ECDF-4E53-82AB-E1587C045891Q34567814-4F6EE75D-2B94-4968-A94B-0239DA1C119BQ35854114-2EDDA0B1-4E0E-4686-89CE-EEC43D65346CQ36146166-DE875435-E56D-4C2B-9E30-09E97310D417Q36418077-CA387C64-280B-4A9F-85AF-C72A688B5C80Q36477235-5F90C0CA-F3CE-4A12-87ED-F5D99BF0076CQ36557338-F70D9BCE-70B7-47AF-8B66-DD3CE1BF7FD8Q36567934-7DAD70CA-7E96-4B6B-BE15-830DCCBDB7ACQ36619103-23C80129-5B3D-4FB0-87F0-CFE4761AA1EDQ36955094-EFF9563A-A12C-4326-8352-D363C200264AQ37212167-715863CB-67F5-4FFB-BF09-79F987AC4CE3Q37278139-32925140-5E5A-4F78-83EB-45D6ADC4BA35Q37393706-6C6E07D5-834B-45D4-9112-A9282F80E636Q37603522-683FA6BA-B09B-44EB-93C5-8C9395D03B7FQ38794459-922B159A-FA93-4CAB-AFD1-56AA211CD0EAQ39345500-B8F91BDF-6D51-4D6F-9124-211813AB3EE2Q39347212-AAB7A43F-49AC-4E8C-B1E8-C66074C30502Q39532008-22F27B5B-F8EA-4B5C-B545-931F520A06B1Q39943631-4FD4DAF8-C52B-4077-92D1-9181BC1E084FQ39959094-D70E6429-BEC0-4A26-BCB0-A0948E6F8A2BQ42365101-BDE0D042-7003-4E79-8448-29D7822D65D2Q42512349-1C33F485-106E-4CA1-9E33-276E8AB1DAFBQ43521061-631AF1BC-8E0A-44C8-AB81-51A69CF481B3Q45082063-48298F33-B3B7-4E7D-82DB-7E25024BD3EBQ47256372-784CA2AA-F5DA-4215-B3D4-76CB5EA7CA74Q48236257-9C02632D-C02F-4DA1-8A02-F486217E2D89Q53705802-621C7502-ECAF-4C55-BD76-5A582BF605BFQ58605959-7D019774-9A0E-419D-BD39-F482A9EFD9BBQ58738098-2C0E9A1F-9F30-4E35-B54B-922C445959DA
P2860
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@en
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@nl
type
label
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@en
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@nl
prefLabel
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@en
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
@nl
P2093
P1476
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression
@en
P2093
José Humberto T G Fregnani
Maria Mitzi Brentani
Mário Mourão Netto
P2888
P356
10.1007/S10549-006-9475-6
P407
P577
2007-01-09T00:00:00Z